PROLOR Aktie

4,07 EUR 1,9809%

Zu Ihrem Onlinebroker

kaufen verkaufen

PROLOR Aktienkurs : 08:05 ( 15 Min. verzögert)
4,07 € Letzter Kurs	1,98% Veränderung	3,99 € Vortag	4,07 € Eröffnungskurs

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
4,07 - 4,07 Tag	5,03 - 2,63 52 Wochen	0 Tag	16 Ø 52 Wochen	4,07 2.000 Stücke	4,19 2.000 Stücke

PROLOR Aktienkurs

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

25.05.

Local billionaire Frost buys 1 million Prolor shares

Miami Beach entrepreneur and billionaire Dr. Phillip Frost's Gamma Trust acquired 1 million shares of developmental-stage biotechnology company Prolor Biotech for $5 million as part of its public offering. Frost is the chairman of the Nes-Ziona, ...
22.05.

Institutional Investors Bet On Prolor, Synergy, Arena Pharmaceuticals

Teva Pharmaceutical Industries (TEVA) Chairman Dr. Phillip Frost bought $5 Million worth of Prolor Biotech (PBTH) stock, according to a filing with the SEC last week. Prolor raised $35 Million from healthcare investors to...

22.05.

Frost Swoops In To Buy More Cheap PROLOR Biotech Shares

Investors may be a bit weary of jumping into PROLOR Biotech (PBTH) after the company announced the closing an underwritten public offering, but that hasn't kept billionaire Phil Frost, chairman...
17.05.

Prolor May Seek Partner to Market Growth Hormone Product

Prolor Biotech Inc. (PBTH), an Israeli company developing improved versions of existing medicines, may seek a partner for its growth-hormone treatment as final trials are set to begin this year, Pres…
16.05.

PROLOR Biotech Announces Closing Of Underwritten Public Offering And Exercise ...

At the closing, PROLOR issued 7475000 shares of its common stock at a price to the public of $5.00 per share, including 975000 shares...